We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$439M
AUM Growth
-$45.1M
Cap. Flow
-$52.5M
Cap. Flow %
-11.96%
Top 10 Hldgs %
59.89%
Holding
34
New
2
Increased
12
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$11.1M
2
CVS icon
CVS Health
CVS
+$6.74M
3
MDT icon
Medtronic
MDT
+$5.35M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$4.56M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.97M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$14.1M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.4M
3
PDCO
Patterson Companies, Inc.
PDCO
+$10.3M
4
ABT icon
Abbott
ABT
+$9.31M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$8.51M

Sector Composition

Rank Sector Weight
1 Healthcare 99.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
1
Medtronic
MDT
$107B
$33.3M 7.57%
320,121
+53,321
+20% +$5.35M
MRK icon
2
Merck
MRK
$307B
$32.6M 7.43%
412,256
-8,616
-2% -$675K
BMY icon
3
Bristol-Myers Squibb
BMY
$123B
$32.6M 7.43%
541,194
-103,339
-16% -$6.22M
GILD icon
4
Gilead Sciences
GILD
$165B
$30.1M 6.86%
477,094
+43,310
+10% +$3M
INCY icon
5
Incyte
INCY
$23.1B
$25.6M 5.82%
284,904
+8,917
+3% +$860K
RVTY icon
6
Revvity
RVTY
$11.9B
$25.4M 5.79%
202,707
-55,015
-21% -$6.32M
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$24.6M 5.6%
215,068
+42,288
+24% +$4.56M
BSX icon
8
Boston Scientific
BSX
$65.1B
$21.2M 4.83%
555,002
-156,480
-22% -$6.03M
BIIB icon
9
Biogen
BIIB
$29.5B
$19.1M 4.35%
67,343
+3,123
+5% +$871K
ABT icon
10
Abbott
ABT
$177B
$18.5M 4.22%
170,219
-91,720
-35% -$9.31M
ELV icon
11
Elevance Health
ELV
$82.9B
$18.2M 4.14%
67,802
-1,200
-2% -$323K
A icon
12
Agilent Technologies
A
$36.8B
$17.1M 3.9%
169,734
-36,882
-18% -$3.56M
BRKR icon
13
Bruker
BRKR
$8.55B
$15.4M 3.5%
386,961
+49,615
+15% +$2.07M
CVS icon
14
CVS Health
CVS
$137B
$14.7M 3.35%
251,781
+108,365
+76% +$6.74M
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$14.1M 3.2%
289,436
-22,192
-7% -$1.2M
CAH icon
16
Cardinal Health
CAH
$52.9B
$13.4M 3.05%
285,281
+50,489
+22% +$2.59M
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.08B
$13.1M 2.99%
25,452
-818
-3% -$414K
LH icon
18
Labcorp
LH
$23.1B
$11.3M 2.58%
+70,146
New +$11.1M
IONS icon
19
Ionis Pharmaceuticals
IONS
$8.75B
$11.2M 2.55%
236,342
+46,361
+24% +$2.58M
PRGO icon
20
Perrigo
PRGO
$1.47B
$9.95M 2.27%
216,780
-73,813
-25% -$3.87M
JNJ icon
21
Johnson & Johnson
JNJ
$599B
$8.5M 1.94%
57,116
+26,837
+89% +$3.97M
HCA icon
22
HCA Healthcare
HCA
$82.2B
$8.22M 1.87%
65,956
+30,680
+87% +$3.8M
LIVN icon
23
LivaNova
LIVN
$4.35B
$6.48M 1.48%
143,361
+34,251
+31% +$1.66M
ELAN icon
24
Elanco Animal Health
ELAN
$12.6B
$5.59M 1.27%
200,111
-57,780
-22% -$1.46M
RIGL icon
25
Rigel Pharmaceuticals
RIGL
$734M
$3.28M 0.75%
+136,529
New +$3.35M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2020 Portfolio in Review

As of Q3 2020, Sector Gamma AS held 34 positions worth $439M, down 9.3% from $484M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS withdrew a net $52.5M in Q3 2020, closing 6 positions and reducing 14 holdings. Its most notable exit was Humana, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Labcorp worth $11.3M.

  • Sector Gamma AS's largest Q3 2020 buy was Labcorp: 70,146 shares worth $11.3M.
  • Sector Gamma AS added most to CVS Health in Q3 2020, an estimated $6.74M increase.
  • Sector Gamma AS's biggest Q3 2020 reduction was Abbott, cutting an estimated $9.31M.
  • Sector Gamma AS fully exited Humana in Q3 2020, selling an estimated $14.1M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $439M portfolio in Q3 2020.
  • Sector Gamma AS opened 2 new positions and closed 6 in Q3 2020.
  • Sector Gamma AS's portfolio value fell 9.3% quarter-over-quarter to $439M.

Based on Sector Gamma AS's 13F filing for Q3 2020, filed 9 Nov 2020.